Eton Pharmaceuticals (NASDAQ:ETON – Free Report) had its price objective trimmed by HC Wainwright from $10.00 to $9.00 in a research note issued to investors on Monday, The Fly reports. HC Wainwright also issued estimates for Eton Pharmaceuticals’ Q2 2024 earnings at $0.02 EPS, Q3 2024 earnings at $0.03 EPS, Q4 2024 earnings at $0.06 […]
NEW YORK , July 3, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. . Such investors are advised to contact Robert.
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc - ETON forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, July 02, 2023 (GLOBE NEWSWIRE) Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (NASDAQ: ETON). Such investors are